European Medicines Agency - Regulatory - Regulation of medicines

5 -Training and educational capacity to build competencies



    Description

Name

 

EPLTN - European Paediatric Liver Transplantation Network

Evidence of collaboration with regulatory authorities Yes For the current study, regulatory authoroties other than the local ethic advisory boards are not involved. For future studies, the following network members have extensive experience in collaborating with regulatory authorities: Birmingham: MHRA (Medicines and Healthcare products Regulatory Agency, UK)
Capacity to provide competent consultation to regulatory authorities Yes see 5.1.
Formal meetings for clinical trials Yes 4-5/year for current trial (planning meetings for PIs, progress meetings for PIs and site staff)
Training courses given over the last 2 years Yes
Training courses received over the last 2 years Yes Network members have received training courses regarding ICH GCP, clinical trial conductance and project management for clinical trials. In addition, selected members have participated in trial specific trainings for a range of industry sponsored trials.
Promotion of participation in clinical trials in countries with limited resources Yes
List of Countries  

Afric + Asien Countries